美国 · SEC FORM 4
LeonaBio, Inc.
LONA · Nasdaq · CIK 0001620463 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-06-24 · Romano Kelly A.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 19,166
- 上期报告
- 23,651
- 日均成交量
- 192,321
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-06-24 | Romano Kelly A | 买入 (P) | Common Stock | 27,400 | USD 2.42 | USD 66,308 | SEC 申报 ↗ |
| 2024-06-21 | Romano Kelly A | 买入 (P) | Common Stock | 15,000 | USD 2.26 | USD 33,900 | SEC 申报 ↗ |
| 2023-12-29 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 163,954 | USD 2.38 | USD 390,211 | SEC 申报 ↗ |
| 2023-12-28 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 409,598 | USD 2.44 | USD 999,419 | SEC 申报 ↗ |
| 2023-12-27 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 32,134 | USD 2.28 | USD 73,266 | SEC 申报 ↗ |
| 2023-06-07 | Gengos Andrew | 买入 (P) | Common Stock | 15,000 | USD 3.43 | USD 51,452 | SEC 申报 ↗ |
| 2023-06-05 | Gengos Andrew | 买入 (P) | Common Stock | 35,000 | USD 3.01 | USD 105,200 | SEC 申报 ↗ |
| 2023-06-02 | Gengos Andrew | 买入 (P) | Common Stock | 20,012 | USD 2.82 | USD 56,441 | SEC 申报 ↗ |
| 2023-03-30 | PICKERING GRANT | 买入 (P) | Common Stock | 15,000 | USD 2.47 | USD 37,050 | SEC 申报 ↗ |
| 2023-03-29 | PICKERING GRANT | 买入 (P) | Common Stock | 10,000 | USD 2.33 | USD 23,300 | SEC 申报 ↗ |
| 2023-03-29 | JOHNSON JAMES A | 买入 (P) | Common Stock | 5,000 | USD 2.40 | USD 12,000 | SEC 申报 ↗ |
| 2022-12-28 | MILESON GLENNA | 买入 (P) | Common Stock | 50,000 | USD 2.85 | USD 142,500 | SEC 申报 ↗ |
| 2022-12-02 | Romano Kelly A | 买入 (P) | Common Stock | 30,000 | USD 3.29 | USD 98,700 | SEC 申报 ↗ |
| 2022-11-15 | MOEBIUS HANS | 买入 (P) | Common Stock | 5,000 | USD 3.29 | USD 16,450 | SEC 申报 ↗ |
| 2022-06-30 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 1,101,362 | USD 2.99 | USD 3,293,072 | SEC 申报 ↗ |
Form 4 申报证据
24 transaction lines in the latest 365-day window; 172 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | Worthington Mark | 卖出 (S) | Common Stock | 1,328 | USD 5.37 | USD 7,131 | SEC 申报 ↗ |
| 2026-03-04 | San Martin Javier | 卖出 (S) | Common Stock | 1,720 | USD 5.37 | USD 9,236 | SEC 申报 ↗ |
| 2026-03-04 | Renninger Robert | 卖出 (S) | Common Stock | 906 | USD 5.37 | USD 4,865 | SEC 申报 ↗ |
展开近期 Form 4 证据 (23 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | Worthington Mark | 卖出 (S) | Common Stock | 1,328 | USD 5.37 | USD 7,131 | SEC 申报 ↗ |
| 2026-03-04 | San Martin Javier | 卖出 (S) | Common Stock | 1,720 | USD 5.37 | USD 9,236 | SEC 申报 ↗ |
| 2026-03-04 | Renninger Robert | 卖出 (S) | Common Stock | 906 | USD 5.37 | USD 4,865 | SEC 申报 ↗ |
| 2026-03-04 | Litton Mark James | 卖出 (S) | Common Stock | 5,156 | USD 5.37 | USD 27,688 | SEC 申报 ↗ |
| 2026-03-04 | CHURCH KEVIN | 卖出 (S) | Common Stock | 1,359 | USD 5.37 | USD 7,298 | SEC 申报 ↗ |
| 2026-03-03 | Worthington Mark | 期权行权／转换 (M) | Common Stock | 5,726 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | San Martin Javier | 期权行权／转换 (M) | Common Stock | 7,418 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | Renninger Robert | 期权行权／转换 (M) | Common Stock | 3,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | Litton Mark James | 期权行权／转换 (M) | Common Stock | 22,254 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | CHURCH KEVIN | 期权行权／转换 (M) | Common Stock | 5,856 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Worthington Mark | 卖出 (S) | Common Stock | 876 | USD 6.88 | USD 6,027 | SEC 申报 ↗ |
| 2026-01-02 | San Martin Javier | 卖出 (S) | Common Stock | 1,644 | USD 6.88 | USD 11,311 | SEC 申报 ↗ |
| 2026-01-02 | Renninger Robert | 卖出 (S) | Common Stock | 297 | USD 6.88 | USD 2,043 | SEC 申报 ↗ |
| 2026-01-02 | Litton Mark James | 卖出 (S) | Common Stock | 2,586 | USD 6.88 | USD 17,792 | SEC 申报 ↗ |
| 2026-01-02 | CHURCH KEVIN | 卖出 (S) | Common Stock | 876 | USD 6.88 | USD 6,027 | SEC 申报 ↗ |
| 2025-12-31 | Worthington Mark | 期权行权／转换 (M) | Common Stock | 3,667 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | San Martin Javier | 期权行权／转换 (M) | Common Stock | 4,667 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | Renninger Robert | 期权行权／转换 (M) | Common Stock | 1,236 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | Litton Mark James | 期权行权／转换 (M) | Common Stock | 10,834 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | CHURCH KEVIN | 期权行权／转换 (M) | Common Stock | 3,667 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-23 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund II, LP | 奖励／授予 (A) | Common Stock | 1,319,026 | USD 6.35 | USD 8,375,815 | SEC 申报 ↗ |
| 2025-11-18 | Renninger Robert | 奖励／授予 (A) | Common Stock | 1,000 | USD 2.31 | USD 2,310 | SEC 申报 ↗ |
| 2025-11-18 | CHURCH KEVIN | 奖励／授予 (A) | Common Stock | 1,000 | USD 2.31 | USD 2,310 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LONA |
| CIK | 0001620463 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 172 transaction lines from 2020-09-18 to 2026-03-04 28 P purchase lines · 40 S sale lines · 104 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.